Status
Conditions
About
This is a non-randomized, single-blind post market clinical follow-up study for which 65 patients will be imaged at Rouge Valley Centenary Hospital (Scarborough and Rouge Hospital) who present with a chronic wound and are receiving standard wound care treatment. The MolecuLight i:X imaging device will be used by the study clinician as an adjunctive tool in the assessment of the wound and will be used to guide the targeted sampling of a wound (with curettage scraping), as per current standard of care in the principal investigator's wound care clinic. The acquired tissue sample will then be analysed using conventional gold standard semi-quantitative culture methods to determine bacterial species present, also as per current standard of care in this clinic.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
65 participants in 1 patient group
Loading...
Central trial contact
Rose Raizman; Liis Teene
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal